NCT07284641

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-05-04Est. Completion: 2030-05-04

Enrollment target: 25 participants

Locations

Contact

Primary ImmunodeficiencyDOCK8Virus Susceptibility

Background: * National Institutes of Health (NIH) researchers have been studying immune cells (white blood cells) to be…

Bethesda, United States

Primary Immunodeficiency Disease

The goal of this phase 3, open-label, single-group clinical trial is to assess the efficacy of Boya IVIG in maintaining …

Multiple LocationsEst. completion Sep 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.